Product
Fosaprepitant dimeglumine
1 clinical trial
1 indication
Clinical trial
Compared With Fosaprepitant Dimeglumine for Injection and Palonosetron Hydrochloride Injection, to Evaluate the Efficacy and Safety of HR20013 for Injection for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic ChemotherapyStatus: Completed, Estimated PCD: 2023-06-19